Venkata S. Jonnakuti, Diana E. Stanescu & Diva D. De Leon. 2020. Maternal-Fetal and Neonatal Endocrinology. Maternal-Fetal and Neonatal Endocrinology
599
610
.
Fiona M. Gribble, Frank Reimann & Geoffrey P. Roberts. 2018. Physiology of the Gastrointestinal Tract. Physiology of the Gastrointestinal Tract
31
70
.
Sara Gibbs & Teresa F. DeGolier. (2008) Neurotensin and cholecystokinin depress motility in isolated Lumbricus terrestris crop-gizzard preparations. Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology 151:4, pages 682-686.
Crossref
Dezheng Zhao & Charalabos Pothoulakis. (2006) Effects of NT on gastrointestinal motility and secretion, and role in intestinal inflammation. Peptides 27:10, pages 2434-2444.
Crossref
Xiao-Tuan Zhao, John H. Walsh, Helen Wong, Lijie Wang & Henry C. Lin. (1999) Intestinal fat-induced inhibition of meal-stimulated gastric acid secretion depends on CCK but not peptide YY. American Journal of Physiology-Gastrointestinal and Liver Physiology 276:2, pages G550-G555.
Crossref
L. Olbe, A. Hamlet & L. Fändriks. 1998. Helicobacter pylori. Helicobacter pylori
148
157
.
Etsuro Shoji, Toshikatsu Okumura & Yutaka Kohgo. (1996) Intraduodenal lipid does not inhibit acid secretion in OLETF rats not expressing CCK-A receptor gene. Digestive Diseases and Sciences 41:11, pages 2174-2179.
Crossref
John CalamJohn Calam. 1996. Clinicians’ Guide to Helicobacter pylori. Clinicians’ Guide to Helicobacter pylori
39
92
.
Steven D. Taylor, Hani C. Soudah, William Y. Chey & James M. Scheiman. (1994) Duodenal acidification and secretin, but not intraduodenal fat, inhibit human gastric acid secretion via prostaglandins. Gastroenterology 107:6, pages 1680-1685.
Crossref
J. CALAM. (1994) Helicobacter pylori. European Journal of Clinical Investigation 24:8, pages 501-510.
Crossref
J. Calam, S. Moss, N. Toker & S. Legon. 1994. Helicobacter pylori. Helicobacter pylori
257
266
.
Ian L. Taylor. (1993) Role of Peptide YY in the Endocrine Control of Digestion. Journal of Dairy Science 76:7, pages 2094-2101.
Crossref
Robert A. Hammer, Alejandro Ochoa, Cesar Fernandez, Atilla Ertan & Akira Arimura. (1992) Somatostatin as a mediator of the effect of neurotensin on pentagastrin-stimulated acid secretion in rats. Peptides 13:6, pages 1175-1179.
Crossref
David Armstrong, Fabiana Castiglione, Carsten Emde, Teresa Cilluffo, Phillipe Duroux, Jacques Koerfer, Evelyne Temler, Cornelius B.H.W. Lamers, Jan B.M.J. Jansens, AndréL. Blum & Jean-Jacques Gonvers. (1992) The effect of continuous enteral nutrition on gastric acidity in humans. Gastroenterology 102:5, pages 1506-1515.
Crossref
C.F. Ferris, J.K. George, G. Eastwood, M. Potegal & R.E. Carraway. (1991) Plasma levels of human neurotensin: Methodological and physiological considerations. Peptides 12:2, pages 215-220.
Crossref
F. A. Sagher, J. A. Dodge, C. F. Johnston, C. Shaw, K. D. Buchanan & K. E. Carr. (2007) Rat small intestinal morphology and tissue regulatory peptides: effects of high dietary fat. British Journal of Nutrition 65:1, pages 21-28.
Crossref
Robert A. Hammer, Cesar Fernandez, Atilla Ertan & Akira Arimura. (1991) Anesthetic dependence of the inhibitory effect of neurotensin on pentagastrin-stimulated acid secretion in rats. A possible role for somatostatin. Life Sciences 48:4, pages 333-339.
Crossref
Robert A. Hammer, Richard E. Hernandez & Ann Shepard. (1990) Inhibitory effect of neurotensin on gastric acid secretion in rats. Digestive Diseases and Sciences 35:4, pages 439-443.
Crossref
Stanisław J. Konturek. 2011. Comprehensive Physiology. Comprehensive Physiology
159
184
.
Craig F. Ferris. 2011. Comprehensive Physiology. Comprehensive Physiology
559
586
.
Ian L. Taylor. 2011. Comprehensive Physiology. Comprehensive Physiology
475
543
.
J. H. Szurszewski & B. F. King. 2011. Comprehensive Physiology. Comprehensive Physiology
519
592
.
Robin D. Rothstein & Ann Ouyang. (1989) Mechanism of action of neurotensin at the ileocecal sphincter region. Life Sciences 45:16, pages 1475-1482.
Crossref
Robert E. Carraway & Manfred Reinecke. 1989. The Comparative Physiology of Regulatory Peptides. The Comparative Physiology of Regulatory Peptides
87
111
.
Robert A. Hammer, Betty Wagner & Hilda S. Soyode. (1988) Inhibitory effect of neurotensin on pentagastrin-stimulated gastric acid secretion in pylorus-ligated rats. Biochemical and Biophysical Research Communications 152:1, pages 231-236.
Crossref
P. H. D. Bladin, D. R. Fletcher, A. Shulkes & K. J. Hardy. (1987) THE VAGUS AND NEUROTENSIN RELEASE IN DUODENAL ULCER—CLINICAL AND EXPERIMENTAL STUDIES. ANZ Journal of Surgery 57:9, pages 661-665.
Crossref
. (2016) 3: Final Report on the Safety Assessment of Oleic Acid, Lauric Acid, Palmitic Acid, Myristic Acid, and Stearic Acid. Journal of the American College of Toxicology 6:3, pages 321-401.
Crossref
R.E. Carraway, S.P. Mitra & D.E. Cochrane. (1987) Structure of a biologically active neurotensin-related peptide obtained from pepsin-treated albumin(s).. Journal of Biological Chemistry 262:13, pages 5968-5973.
Crossref
Mitsuyoshi Namba, Tatsuo Matsuyama, Hidehiko Itoh, Yasuharu Imai, Hiroaki Horie & Seiichiro Tarui. (1986) Inhibition of pentagastrin-stimulated gastric acid secretion by intraileal administration of bile and elevation of plasma concentrations of gut glucagon-like immunoreactivity in anesthetized dogs. Regulatory Peptides 15:2, pages 121-128.
Crossref
J. Holst Pedersen, P. Skov Olsen & P. Kirkegaard. (1986) Effect of neurotensin and neurotensin fragments on gastric acid secretion in man. Regulatory Peptides 15:1, pages 77-86.
Crossref
Y.C. Lee, A.J. Bacarese-Hamilton, S.M. Wood, L.H. Blumgart & S.R. Bloom. (1985) Chromatographic characterisation of neurotensin-like immunoreactivity in plasma and tissue extracts from hepatoma patients. Clinica Chimica Acta 149:1, pages 29-36.
Crossref
Y. C. Lee, J. M. Allen, L. O. Uttenthal, P. M. Roberts, S. S. Gill & S. R. Bloom. (1985) Quantitation and characterization of human plasma neurotensin-like immunoreactivity in response to a meal. Digestive Diseases and Sciences 30:2, pages 129-133.
Crossref
Manfred Reinecke. (1985) Neurotensin. Progress in Histochemistry and Cytochemistry 16:1, pages III-172.
Crossref
ÅKE RÖKAEUS. (2008) Increase in neurotensin‐like immunoreactivity in rat plasma after administration of calcium, bombesin and fat and its inhibition by somatostatin. Acta Physiologica Scandinavica 122:3, pages 261-267.
Crossref
J. Miskowiak, J. Holst Pedersen, B. Andersen & F. Stadil. (1984) Plasma levels of neurotensin in gastroplasty for morbid obesity. Regulatory Peptides 9:4, pages 263-269.
Crossref
S. S. Gill, Y. C. Lee, M. A. Ghatei, M. Ghiglione, L. O. Uttenthal & S. R. Bloom. (2007) THE USE OF A RAT ISOLATED ILEAL PREPARATION TO INVESTIGATE THE RELEASE OF NEUROTENSIN. Clinical and Experimental Pharmacology and Physiology 11:5, pages 457-465.
Crossref
V. E. Eysselein. (1984) Neurotensin — Was ist gesichert über seine Rolle als Hormon im Magen-Darmtrakt?Neurotensin — What is known about its role as a hormone in the gastrointestinal tract?. Klinische Wochenschrift 62:11, pages 523-530.
Crossref
P S Olsen, J H Pedersen, P Kirkegaard, H Been, F Stadil, J Fahrenkrug & J Christiansen. (1984) Neurotensin induced inhibition of gastric acid secretion in duodenal ulcer patients before and after parietal cell vagotomy.. Gut 25:5, pages 481-484.
Crossref
ÅKE RÖKAEUS & AHMAD AL‐SAFFAR. (2008) The importance of bile and pancreatic juice for fat‐induced release of neurotensin‐like immunoreactivity (NTLI) from the small intestine of the rat. Acta Physiologica Scandinavica 119:1, pages 33-37.
Crossref
Robert E. Carraway, Susan E. Ruane & Rita S. Ritsema. (1983) Radioimmunoassay for Lys8, Asn9, neurotensin 8–13: Tissue and subcellular distribution of immunoreactivity in chickens. Peptides 4:1, pages 111-116.
Crossref
Sune Rosell. (1982) THE ROLE OF NEUROTENSIN IN THE UPTAKE AND DISTRIBUTION OF FAT. Annals of the New York Academy of Sciences 400:1 Neurotensin,, pages 183-197.
Crossref
Emeran A. Mayer, Janet Elashoff, Viktor Mutt & John H. Walsh. (1982) Reassessment of Gastric Acid Inhibition by Cyholecystokinin and Gastric Inhibitory Polypeptide in Dogs. Gastroenterology 83:5, pages 1047-1050.
Crossref
G.E. Feurle, I. Baca & W. Knauf. (1982) Atropine depresses release of neurotensin and its effect on the exocrine pancreas. Regulatory Peptides 4:2, pages 75-82.
Crossref
P. M. HELLSTRÖM, G. NYLANDER & S. ROSELL. (2008) Effects of neurotensin on the transit of gastrointestinal contents in the rat. Acta Physiologica Scandinavica 115:2, pages 239-243.
Crossref
Å. RÖKAEUS, N. YANAIHARA & T. J. McDONALD. (2008)
Increased concentration of neurotensin‐like immunoreactivity (NTLI) in rat plasma after administration of bombesin and bombesin‐related peptides (porcine and chicken gastrin‐releasing peptides)
1
. Acta Physiologica Scandinavica 114:4, pages 605-610.
Crossref
B.H. Hirst, B. Shaw & Lesley Wilson. (1982) Neurotensin inhibition of gastric exocrine secretions in the cat. Regulatory Peptides 3:3-4, pages 289-301.
Crossref
O. FLATEN & L. E. HANSSEN. (2008) Concentration of neurotensin in human plasma after glucose, meals and lipids. Acta Physiologica Scandinavica 114:2, pages 311-313.
Crossref
DavidR. Brown & RichardJ. Miller. 1982.
271
280
.
Sune Rosell & Åke Rökaeus. (2008) Actions and possible hormonal functions of circulating neurotensin. Clinical Physiology 1:1, pages 3-20.
Crossref